[go: up one dir, main page]

BR9813740A - Teriparatìdeo cristalino - Google Patents

Teriparatìdeo cristalino

Info

Publication number
BR9813740A
BR9813740A BR9813740-9A BR9813740A BR9813740A BR 9813740 A BR9813740 A BR 9813740A BR 9813740 A BR9813740 A BR 9813740A BR 9813740 A BR9813740 A BR 9813740A
Authority
BR
Brazil
Prior art keywords
teriparatide
crystalline
purification
pure
preparation
Prior art date
Application number
BR9813740-9A
Other languages
English (en)
Inventor
Faming Zhang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9813740A publication Critical patent/BR9813740A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"TERIPARATìDEO CRISTALINO"<D>. Formas cristalinas puras estáveis de hormónio paratiróide, particularmente teriparatídeo, são descritas, bem como métodos de preparo e purificação.
BR9813740-9A 1997-12-18 1998-12-08 Teriparatìdeo cristalino BR9813740A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6987597P 1997-12-18 1997-12-18
PCT/US1998/026044 WO1999031137A1 (en) 1997-12-18 1998-12-08 Crystalline teriparatide

Publications (1)

Publication Number Publication Date
BR9813740A true BR9813740A (pt) 2000-10-10

Family

ID=22091750

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813740-9A BR9813740A (pt) 1997-12-18 1998-12-08 Teriparatìdeo cristalino

Country Status (24)

Country Link
US (1) US6590081B1 (pt)
EP (1) EP0926158B1 (pt)
JP (1) JP2002508395A (pt)
KR (1) KR20010033268A (pt)
CN (1) CN1281467A (pt)
AR (1) AR038648A1 (pt)
AT (1) ATE245165T1 (pt)
AU (1) AU748271B2 (pt)
BR (1) BR9813740A (pt)
CA (1) CA2315103A1 (pt)
DE (1) DE69816409T2 (pt)
DK (1) DK0926158T3 (pt)
EA (1) EA200000672A1 (pt)
ES (1) ES2202729T3 (pt)
HU (1) HUP0100075A2 (pt)
ID (1) ID25660A (pt)
IL (1) IL136824A0 (pt)
NO (1) NO20003131D0 (pt)
PE (1) PE20000056A1 (pt)
PL (1) PL341209A1 (pt)
PT (1) PT926158E (pt)
TR (1) TR200002179T2 (pt)
WO (1) WO1999031137A1 (pt)
ZA (1) ZA9811407B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
BRPI0215192B8 (pt) * 2001-12-18 2021-07-27 Eidgenoessische Technische Hochschule Zuerich peptídeo de fusão, kit e matriz que compreendem o mesmo, e método para criar uma matriz
EP1864681A1 (en) 2001-12-18 2007-12-12 Eidgenössische Technische Hochschule Zürich Growth factor modified protein matrices for tissue engineering
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
WO2004022033A1 (en) * 2002-09-04 2004-03-18 Microchips, Inc. Method and device for the controlled delivery of parathyroid hormone
BR0317888A (pt) 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US7244709B2 (en) * 2004-05-10 2007-07-17 Nastech Pharamecutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
US7488316B2 (en) 2005-01-25 2009-02-10 Microchips, Inc. Control of drug release by transient modification of local microenvironments
US7691105B2 (en) 2005-09-26 2010-04-06 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique
US20070088436A1 (en) * 2005-09-29 2007-04-19 Matthew Parsons Methods and devices for stenting or tamping a fractured vertebral body
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
AU2006315132A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20070168041A1 (en) * 2006-01-17 2007-07-19 Sudhakar Kadiyala Method and instruments for intervertebral disc augmentation through a pedicular approach
PL2136850T3 (pl) 2007-04-13 2012-07-31 Kuros Biosurgery Ag Polimeryczny uszczelniacz tkankowy
MX2010001612A (es) * 2007-08-09 2010-07-01 Usv Ltd Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34).
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US8241294B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Instruments for expandable corpectomy spinal fusion cage
US8241363B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Expandable corpectomy spinal fusion cage
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
WO2009083544A2 (en) 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
US8876905B2 (en) 2009-04-29 2014-11-04 DePuy Synthes Products, LLC Minimally invasive corpectomy cage and instrument
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
US8865220B2 (en) 2010-06-14 2014-10-21 Kaohsiung Medical University Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres
EP2686027B1 (en) 2011-03-16 2021-05-05 Kuros Biosurgery AG Pharmaceutical formulation for use in spinal fusion
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
CN104910269B (zh) * 2015-06-02 2018-08-17 成都圣诺生物科技股份有限公司 一种合成特立帕肽的方法
WO2019059302A1 (ja) * 2017-09-22 2019-03-28 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62106000A (ja) 1985-10-30 1987-05-16 Fujitsu Ltd 生体高分子結晶自動作製装置
AU2788089A (en) * 1987-10-20 1989-05-23 Michael F. Holick Regulation of cell proliferation and differentiation using peptides
EP0553539A1 (en) 1991-10-09 1993-08-04 Schering Corporation Crystal forming device and automated crystallization system
US5400741A (en) 1993-05-21 1995-03-28 Medical Foundation Of Buffalo, Inc. Device for growing crystals
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US5419278A (en) * 1994-05-25 1995-05-30 Carter; Daniel C. Vapor equilibration tray for growing protein crystals
CA2178894A1 (en) 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use

Also Published As

Publication number Publication date
WO1999031137A1 (en) 1999-06-24
EA200000672A1 (ru) 2000-12-25
ES2202729T3 (es) 2004-04-01
DE69816409D1 (de) 2003-08-21
ZA9811407B (en) 2000-07-13
TR200002179T2 (tr) 2001-07-23
PT926158E (pt) 2003-11-28
IL136824A0 (en) 2001-06-14
ID25660A (id) 2000-10-19
DE69816409T2 (de) 2004-06-09
PE20000056A1 (es) 2000-02-08
EP0926158B1 (en) 2003-07-16
US6590081B1 (en) 2003-07-08
KR20010033268A (ko) 2001-04-25
AR038648A1 (es) 2005-01-26
EP0926158A1 (en) 1999-06-30
NO20003131L (no) 2000-06-16
CN1281467A (zh) 2001-01-24
DK0926158T3 (da) 2003-11-10
HUP0100075A2 (hu) 2001-05-28
AU1632699A (en) 1999-07-05
CA2315103A1 (en) 1999-06-24
NO20003131D0 (no) 2000-06-16
AU748271B2 (en) 2002-05-30
ATE245165T1 (de) 2003-08-15
JP2002508395A (ja) 2002-03-19
PL341209A1 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
BR9813740A (pt) Teriparatìdeo cristalino
ATE380822T1 (de) Funf-helix protein
ATE369434T1 (de) Adenoassoziierte virusvektoren und ihre verwendungen
DK1242452T3 (da) Kimære natriuretiske peptider
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
SE0002102D0 (sv) Chemical compound
DK1265889T3 (da) Lægemidler imod virussygdomme
GB0011203D0 (en) Chemical compounds
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DE69736847D1 (de) Herstellung von Laktamen aus aliphatischen Alpha,Omega-Dinitrilen
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
SE9802729D0 (sv) Novel Compounds
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
WO2004000859A3 (en) Etoposide analogs and methods of use thereof
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
BR9813817A (pt) Análogos de hemiasterlina
ATE297903T1 (de) Substituierte phenyluracile
ITTO991172A0 (it) Procedimento di purificazione biologica di un&#39;acqua contenente perclor ato di ammonio.
BR0312889A (pt) Polipeptìdeo t20 peguilado
ES2014546A6 (es) Procedimiento para la obtencion de fctor activador de neutrofilos.
DE69725018D1 (de) Gereinigte telomerase
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
ATE335824T1 (de) Isolierte luziferasen sowie deren verwendung
DK0939769T3 (da) Vertebrat-Smoothened-proteiner

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.